Nick Naclerio brings an unusually broad technical background spanning defense, semiconductors, and genomics toolmaking—from USAF lab officer to DARPA assistant director to founding Motorola Life Sciences and early Illumina involvement—before moving into venture capital at Illumina Ventures. He positions genomics as a general-purpose technology that will transform not just medicine but also climate change solutions through agriculture and food systems, investing over $500M in companies where genomics fundamentally changes standard of care rather than incremental improvements.